PureTech’s deupirfenidone gets FDA and EC Orphan Drug Designations for idiopathic pulmonary fibrosis

PureTech’s deupirfenidone gets FDA and EC Orphan Drug Designations for idiopathic pulmonary fibrosis

PureTech Health’s deupirfenidone (LYT-100) has received Orphan Drug Designation to treat idiopathic pulmonary fibrosis (IPF). The…

Continue Reading
Fibroblasts as regulators of lung immunity, repair and fibrosis

Fibroblasts as regulators of lung immunity, repair and fibrosis

Wijsenbeek, M. & Cottin, V. Spectrum of fibrotic lung diseases. N. Engl. J. Med. 383, 958–968…

Continue Reading
Blocking key protein restores healthy lung function and reduces fibrosis in mice

Blocking key protein restores healthy lung function and reduces fibrosis in mice

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing…

Continue Reading
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD

Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD

Nerandomilast met its primary end point of absolute change from baseline in forced vital capacity (FVC)…

Continue Reading